Gonadal hormone substitutes: Effects on the cardiovascular system
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 7 (1) , 43-51
- https://doi.org/10.1007/bf01674813
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Tamoxifen Inhibits Arterial Accumulation of LDL Degradation Products and Progression of Coronary Artery Atherosclerosis in MonkeysArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996
- Responses of Smooth Muscle Cells to Platelet-Derived Growth Factor Are Inhibited by Herbimycin-A Tyrosine Kinase InhibitorBiochemical and Biophysical Research Communications, 1993
- Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- “Variant” angina: One aspect of a continuous spectrum of vasospastic myocardial ischemiaThe American Journal of Cardiology, 1978
- Estrogenic Activity of Isoflavone Derivatives Extracted and Prepared from Soybean Oil MealScience, 1953